Clinical Trial Update: Molecular Determinants for Therapy Response on Renal Cell Carcinoma [NA]

View source ↗

Summary

This clinical trial update investigates molecular determinants of therapy response in renal cell carcinoma; current status and trial phase are not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: Heidelberg University | Conditions: Renal Cell Carcinoma | NA | Status: UNKNOWN